Pegylated Dickeya Chrysanthemi L-asparaginase

Pegylated Dickeya Chrysanthemi L-asparaginase Uses, Dosage, Side Effects, Food Interaction and all others data.

Pegylated Dickeya Chrysanthemi L-asparaginase is under investigation in clinical trial NCT02257684 (A Dose Confirmation and Pharmacokinetic Study of Pegylated Dickeya Chrysanthemi L-asparaginase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)).

Trade Name Pegylated Dickeya Chrysanthemi L-asparaginase
Generic Pegcrisantaspase
Pegcrisantaspase Other Names Asparec, Mpeg-r-crisantaspase, Pegcrisantaspase, Pegylated dickeya chrysanthemi l-asparaginase, Pegylated erwinia chrysanthemi l-asparaginase
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Pegylated Dickeya Chrysanthemi L-asparaginase
Pegylated Dickeya Chrysanthemi L-asparaginase

Innovators Monograph

You find simplified version here Pegylated Dickeya Chrysanthemi L-asparaginase


*** Taking medicines without doctor's advice can cause long-term problems.
Share